Skip to main content

Elutia Inc.

ELUT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001708527

No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Elutia Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of ELUT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3124−7
Shares1.70M2.05M+347.9K (+20.4%)
Value$23.5M$19.7M−$3.83M (−16.3%)

New holders (4)

Institutions that held Elutia Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to ELUT in Q2 2021
InstitutionSharesValue% of portfolio
Brown Advisory Inc282,249$2.71M0.00%
Birchview Capital, LP30,000$288.0K0.17%
Ergoteles LLC10,000$96.0K0.00%
O'Shaughnessy Asset Management, LLC2,871$28.0K0.00%

Sold out (11)

Institutions that held Elutia Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of ELUT in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Driehaus Capital Management LLC305,485$4.22M
Northern Trust Corp25,230$348.0K
Geode Capital Management, LLC17,941$247.0K
State Street Corp15,467$214.0K
Laurion Capital Management LP10,000$138.0K
California State Teachers Retirement System3,367$47.0K
Deutsche Bank AG1,421$20.0K
American International Group, Inc.1,298$18.0K
Tower Research Capital LLC (TRC)651$9.00K
Ameritas Investment Partners, Inc.185$3.00K
Bank of Montreal142$2.00K